Biosingularity

Melanoma Drug Prolonged Patients’ Lives in Clinical Trial

Posted on: January 24, 2011

Advanced melanoma patients taking an experimental drug aimed at a particular mutation in their tumors lived longer than patients who did not receive the drug in a decisive clinical trial, the drug’s manufacturer, Roche, said Wednesday.

via Melanoma Drug Prolonged Patients’ Lives in Clinical Trial – NYTimes.com.

About these ads

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 855 other followers

Follow me on Twitter

Medical Professional Database Award

 Doctor

Visitors Now

who's online

Blog Stats

  • 1,401,896 hits

Categories

Top Rated

Flickr Photos

More Photos

Maps

Networked blogs

Follow

Get every new post delivered to your Inbox.

Join 855 other followers

%d bloggers like this: